ad image

Novel Therapy

1 / 1
Inceptor Bio
Cancer Research

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

Inceptor Bio

PR-M06-21-018Jun 14, 2021
Rising Demand for Novel Cancer Treatment Approaches to Propel Cell Line Development Market through 2024
Cell Line Development

Rising Demand for Novel Cancer Treatment Approaches to Propel Cell Line Development Market through 2024

Global Market Insights

PAO-M11-19-NI-007Nov 20, 2019
Focusing on the Tumor Microenvironment Leads to Novel Drug Targets
Tumor Microenvironment

Focusing on the Tumor Microenvironment Leads to Novel Drug Targets

Shaan C. Gandhi, M.D., Ph.D.

Pyxis Oncology

PAP-Q3-19-CL-023Oct 28, 2019
Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?
Novel Therapies

Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?

Pharma's Almanac

PAP-Q2-2019-NI-007May 23, 2019
Albert Einstein College of Medicine
Novel Therapy

Novel Combination Therapy Promotes Wound Healing

Albert Einstein College of Medicine

PR-M10-18-NI-096Oct 29, 2018
First Light Biosciences:
Drug Development

First Light Biosciences Develops a Novel Method for Rapidly Determining Effective Antibiotics for Treating Infections

First Light Biosciences:

PR-M10-18-NI-010Oct 02, 2018
SRI Biosciences
Artificial Intelligence

AI-Guided Cancer Therapy Platform from SRI International Identifies Novel Molecular Targets for Aggressive Form of Breast Cancer

SRI Biosciences

PR-M04-18-NI-71Apr 20, 2018
FIMECS, Inc.
Immuno-Oncology

FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies

FIMECS, Inc.

PR-M04-18-NI-44Apr 13, 2018
Biostage, Inc.
Fast Track

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

Biostage, Inc.

PR-M04-18-NI-002-4473Apr 02, 2018
Celgene, Vividion Therapeutics Collaborate on Novel Protein Drugs
Drug Development

Celgene, Vividion Therapeutics Collaborate on Novel Protein Drugs

Guy Tiene

Nice Insight

PAO-M03-18-NI-005Mar 08, 2018
Rexgenero
Clinical Trials

Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)

Rexgenero

PR-M01-18-NI-093Jan 30, 2018
China FDA Publishes Guidance for Priority Review
CFDA

China FDA Publishes Guidance for Priority Review

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M01-18-NI-013Jan 09, 2018
Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases
Strategic Partnership

Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases

Nice Insight

PAO-M11-17-NI-022Nov 14, 2017
1 / 1